 Arcadia Biosciences, Inc. Nasdaq: RKDA, a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced that it has entered into a definitive agreement with an institutional investor for the exercise of certain existing warrants to purchase up to an aggregate of 641,416 shares of common stock at a reduced exercise price of 3.975 per share. Additionally, Arcadia has agreed to issue to the investor new unregistered warrants to purchase up to an aggregate of 641,416 shares of common stock shares at an exercise price of 3.85 per share and with an exercise period of five and one-half years from the date of issuance. The closing of the transaction is expected to occur on or about July 8, 2020, subject to the satisfaction of customary closing conditions. 